ADALIMUMAB-ADAZ

ADALIMUMAB-ADAZ was reported 55074 times

ADALIMUMAB-ADAZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 504 0.7545
1 LUPUS VULGARIS 937 0.7437
2 HEPATIC ENZYME 100 0.6711
3 GRIP STRENGTH 142 0.6201
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1224 0.6111
5 RED BLOOD CELL SEDIMENTATION RATE 167 0.5986
6 FACET JOINT SYNDROME 1861 0.5710
7 SWOLLEN JOINT COUNT INCREASED 1792 0.5614
8 RHEUMATIC FEVER 2499 0.5601
9 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 67 0.5583
10 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 187 0.5565
11 C-REACTIVE PROTEIN 505 0.5448
12 HYPOCHOLESTEROLAEMIA 191 0.5411
13 SYNOVIAL FLUID ANALYSIS 47 0.5402
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1012 0.4879
15 SWOLLEN JOINT COUNT 121 0.4840
16 RETINITIS 833 0.4818
17 DISLOCATION OF VERTEBRA 1018 0.4459
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3154 0.4398
19 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 237 0.4225
20 DUODENAL ULCER PERFORATION 3100 0.4164
21 PARADOXICAL PSORIASIS 195 0.4158
22 RHEUMATOID FACTOR POSITIVE 2356 0.4075
23 X-RAY ABNORMAL 728 0.4067
24 MUSCULOSKELETAL DEFORMITY 86 0.3675
25 PEMPHIGUS 4094 0.3271
26 PERIPHERAL VENOUS DISEASE 1337 0.3271
27 C-REACTIVE PROTEIN ABNORMAL 2028 0.3158
28 HELICOBACTER INFECTION 3106 0.3019
29 HAND DEFORMITY 3936 0.2998
30 BODY HEIGHT BELOW NORMAL 191 0.2970
31 SERONEGATIVE ARTHRITIS 340 0.2967
32 ILEOCAECAL RESECTION 102 0.2965
33 FOLLICULITIS 2994 0.2852
34 MUSCLE INJURY 2365 0.2851
35 SHORT STATURE 70 0.2672
36 CUTANEOUS LEISHMANIASIS 66 0.2609
37 BONE EROSION 897 0.2534
38 VAGINAL FLATULENCE 76 0.2508
39 BREAST CANCER STAGE III 1584 0.2443
40 STEROID DEPENDENCE 213 0.2426
41 SYNOVITIS 4367 0.2420
42 JOINT DESTRUCTION 359 0.2307
43 AMAUROSIS FUGAX 236 0.2191
44 LOOSE BODY IN JOINT 58 0.2180
45 SARCOID-LIKE REACTION 55 0.2132
46 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1376 0.2117
47 ENTHESOPATHY 319 0.2038
48 PERICARDITIS 3411 0.2028
49 PORPHYRIA ACUTE 289 0.2014
50 TERMINAL ILEITIS 123 0.2003
51 LIP DRY 1820 0.2002
52 JUVENILE IDIOPATHIC ARTHRITIS 470 0.1920
53 ONYCHOMADESIS 795 0.1892
54 GLOSSODYNIA 4225 0.1885
55 GRIP STRENGTH DECREASED 1641 0.1863
56 HYPERCHOLESTEROLAEMIA 1785 0.1847
57 ANKLE ARTHROPLASTY 65 0.1791
58 WOUND INFECTION 1962 0.1790
59 SAPHO SYNDROME 44 0.1781
60 PALMOPLANTAR PUSTULOSIS 93 0.1758
61 JOINT RANGE OF MOTION DECREASED 2354 0.1753
62 CATARRH 157 0.1737
63 FAECAL CALPROTECTIN ABNORMAL 72 0.1735
64 BURSITIS 2062 0.1698
65 GRANULOMA SKIN 139 0.1693
66 BLEPHAROSPASM 1055 0.1674
67 DRUG TOLERANCE DECREASED 459 0.1633
68 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 366 0.1587
69 MYCOBACTERIUM MARINUM INFECTION 50 0.1538
70 LIVE BIRTH 1275 0.1523
71 PROCTOCOLECTOMY 43 0.1410
72 DRUG SPECIFIC ANTIBODY 191 0.1394
73 WOUND 3859 0.1379
74 GENERALISED PUSTULAR PSORIASIS 39 0.1345
75 ANASTOMOTIC STENOSIS 50 0.1344
76 IRIS ADHESIONS 68 0.1326
77 PLASMABLASTIC LYMPHOMA 47 0.1313
78 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1450 0.1309
79 SYSTEMIC LUPUS ERYTHEMATOSUS 4632 0.1304
80 FIBROMYALGIA 3170 0.1303
81 ONYCHOMYCOSIS 565 0.1286
82 AUTOIMMUNE DISORDER 1254 0.1285
83 IRRITABLE BOWEL SYNDROME 2730 0.1272
84 POLYCHONDRITIS 52 0.1232
85 PYODERMA GANGRENOSUM 433 0.1202
86 CONTRAINDICATED PRODUCT ADMINISTERED 3643 0.1202
87 NEUROSARCOIDOSIS 45 0.1197
88 FINGER DEFORMITY 575 0.1186
89 DEATH NEONATAL 164 0.1178
90 NAIL DISORDER 1030 0.1176
91 ARTHRITIS ENTEROPATHIC 38 0.1166
92 INFUSION SITE REACTION 348 0.1164
93 LUPUS-LIKE SYNDROME 1031 0.1136
94 LIVER INJURY 2740 0.1115
95 MEAN PLATELET VOLUME DECREASED 93 0.1108
96 BLOOD PARATHYROID HORMONE DECREASED 164 0.1106
97 HEPATOSPLENIC T-CELL LYMPHOMA 41 0.1105
98 POLYARTHRITIS 576 0.1092
99 PSORIATIC ARTHROPATHY 4430 0.1090
100 ANTIBODY TEST POSITIVE 180 0.1084
101 OBESITY 1727 0.1083
102 DISSEMINATED TUBERCULOSIS 278 0.1083
103 VASCULAR ACCESS COMPLICATION 86 0.1062
104 TENOSYNOVITIS 289 0.1047
105 SACROILIITIS 195 0.1032
106 FAECAL CALPROTECTIN INCREASED 325 0.1025
107 TENOSYNOVITIS STENOSANS 57 0.1023
108 PUSTULAR PSORIASIS 351 0.1021
109 RHEUMATOID LUNG 93 0.0974
110 OVERLAP SYNDROME 67 0.0957
111 TYPE 2 DIABETES MELLITUS 3169 0.0940
112 EXOSTOSIS 859 0.0940
113 PANNICULITIS 226 0.0933
114 RHEUMATOID NODULE 255 0.0925
115 PRODUCT SUBSTITUTION 37 0.0916
116 PRODUCT LABEL CONFUSION 525 0.0900
117 AXIAL SPONDYLOARTHRITIS 79 0.0899
118 VISCERAL LEISHMANIASIS 64 0.0886
119 BURNS SECOND DEGREE 155 0.0883
120 MATERNAL EXPOSURE TIMING UNSPECIFIED 330 0.0878
121 IMPAIRED HEALING 2862 0.0871
122 VULVAL DISORDER 57 0.0862
123 SCIATICA 1361 0.0853
124 SPONDYLOARTHROPATHY 51 0.0850
125 ILEAL ULCER 86 0.0850
126 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 38 0.0848
127 DACTYLITIS 83 0.0845
128 BACK INJURY 904 0.0830
129 PULMONARY FIBROSIS 1549 0.0807
130 INTESTINAL ANASTOMOSIS 50 0.0776
131 ILEAL STENOSIS 138 0.0776
132 THERAPEUTIC PRODUCT EFFECT DECREASED 3475 0.0775
133 HISTOPLASMOSIS DISSEMINATED 123 0.0775
134 SPONDYLITIS 277 0.0761
135 FOOT DEFORMITY 829 0.0747
136 ARTHROPATHY 4146 0.0745
137 C-REACTIVE PROTEIN INCREASED 2668 0.0733
138 BREAST CANCER STAGE II 608 0.0730
139 IGA NEPHROPATHY 119 0.0717
140 ANAL STENOSIS 38 0.0713
141 LOWER LIMB FRACTURE 1365 0.0710
142 SCLERITIS 113 0.0705
143 WALKING AID USER 462 0.0700
144 DRUG TOLERANCE 354 0.0699
145 DRUG LEVEL ABNORMAL 37 0.0697
146 PRESCRIBED OVERDOSE 1338 0.0691
147 ALANINE AMINOTRANSFERASE ABNORMAL 144 0.0682
148 LOSS OF THERAPEUTIC RESPONSE 217 0.0680
149 JOINT DISLOCATION 710 0.0671
150 DRUG SPECIFIC ANTIBODY PRESENT 432 0.0664
151 GAIT INABILITY 2181 0.0652
152 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 38 0.0643
153 IRIDOCYCLITIS 201 0.0635
154 FEMALE GENITAL TRACT FISTULA 108 0.0632
155 ULCER HAEMORRHAGE 423 0.0624
156 ENTEROCUTANEOUS FISTULA 55 0.0624
157 HIDRADENITIS 564 0.0618
158 ENCEPHALITIS AUTOIMMUNE 80 0.0608
159 POUCHITIS 52 0.0604
160 INFUSION RELATED REACTION 4005 0.0604
161 COELIAC DISEASE 592 0.0603
162 BLOOD CHOLESTEROL INCREASED 2809 0.0602
163 LARGE INTESTINAL STENOSIS 120 0.0600
164 OSTEOARTHRITIS 2497 0.0588
165 LIVER FUNCTION TEST INCREASED 1241 0.0577
166 RHEUMATOID ARTHRITIS 6561 0.0577
167 EYE INJURY 175 0.0575
168 LOWER RESPIRATORY TRACT INFECTION 2578 0.0566
169 MEAN CELL VOLUME DECREASED 87 0.0564
170 PROCTITIS 157 0.0560
171 UVEITIS 758 0.0558
172 ERYTHRODERMIC PSORIASIS 46 0.0558
173 BLOODY DISCHARGE 63 0.0551
174 MEAN CELL HAEMOGLOBIN DECREASED 99 0.0540
175 VARICELLA ZOSTER VIRUS INFECTION 112 0.0540
176 PRESCRIBED UNDERDOSE 1077 0.0539
177 NIGHT SWEATS 1737 0.0539
178 HIP ARTHROPLASTY 822 0.0536
179 PULMONARY SARCOIDOSIS 60 0.0534
180 INFLAMMATION 2726 0.0528
181 HYPERSENSITIVITY PNEUMONITIS 60 0.0527
182 GENITAL ULCERATION 40 0.0519
183 TREATMENT FAILURE 4285 0.0517
184 RASH VESICULAR 247 0.0510
185 HEPATIC ENZYME INCREASED 3474 0.0509
186 NORMAL NEWBORN 274 0.0504
187 GRANULOMA 173 0.0499
188 BLISTER 2801 0.0498
189 FRACTURE DELAYED UNION 42 0.0497
190 MOBILITY DECREASED 3565 0.0496
191 URINARY TRACT DISORDER 221 0.0490
192 DRUG INTOLERANCE 4718 0.0488
193 DEMYELINATION 197 0.0480
194 CONGENITAL ANOMALY 370 0.0477
195 HEPATIC CIRRHOSIS 894 0.0475
196 HENOCH-SCHONLEIN PURPURA 102 0.0466
197 DISCOMFORT 2825 0.0463
198 PARADOXICAL DRUG REACTION 170 0.0462
199 DERMATITIS PSORIASIFORM 94 0.0460
200 TASTE DISORDER 928 0.0457
201 ANKYLOSING SPONDYLITIS 598 0.0453
202 HYPOPNOEA 156 0.0449
203 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 106 0.0446
204 WHEEZING 2635 0.0444
205 THERAPY NON-RESPONDER 1976 0.0439
206 JOINT EFFUSION 303 0.0439
207 OSTEOPOROTIC FRACTURE 82 0.0428
208 GASTROINTESTINAL WALL THICKENING 64 0.0427
209 CUSHINGOID 137 0.0426
210 SWELLING 3929 0.0419
211 STOMATITIS 2534 0.0417
212 SKIN NECROSIS 216 0.0416
213 MATERNAL EXPOSURE DURING PREGNANCY 3679 0.0412
214 INFECTION REACTIVATION 47 0.0410
215 WHEELCHAIR USER 181 0.0407
216 INTESTINAL DILATATION 54 0.0405
217 ADVERSE REACTION 537 0.0405
218 INJURY 2840 0.0404
219 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 53 0.0402
220 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 689 0.0401
221 NEUROENDOCRINE CARCINOMA OF THE SKIN 39 0.0398
222 PULMONARY TUBERCULOSIS 170 0.0398
223 MYCOBACTERIAL INFECTION 67 0.0389
224 PNEUMONIA LEGIONELLA 62 0.0387
225 LUNG DISORDER 1893 0.0386
226 JOINT SWELLING 4643 0.0384
227 ANAL ABSCESS 207 0.0384
228 MUSCULOSKELETAL STIFFNESS 3362 0.0383
229 KNEE ARTHROPLASTY 798 0.0379
230 COLITIS ULCERATIVE 1689 0.0377
231 ANAL FISTULA 199 0.0373
232 JOINT STIFFNESS 978 0.0372
233 CYSTOID MACULAR OEDEMA 70 0.0371
234 INTENTIONAL PRODUCT USE ISSUE 3253 0.0371
235 MUSCULOSKELETAL PAIN 1940 0.0370
236 GENERAL PHYSICAL HEALTH DETERIORATION 4284 0.0370
237 ALLERGY TO CHEMICALS 46 0.0369
238 INTESTINAL FISTULA 52 0.0369
239 ILL-DEFINED DISORDER 2234 0.0367
240 ILEOSTOMY 93 0.0364
241 MACULAR DEGENERATION 435 0.0364
242 CHRONIC SINUSITIS 135 0.0359
243 ALCOHOL POISONING 96 0.0358
244 CUTANEOUS T-CELL LYMPHOMA 45 0.0357
245 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 268 0.0357
246 STENOSIS 67 0.0356
247 SUSPECTED OFF LABEL USE 161 0.0356
248 OEDEMA 1909 0.0352
249 ROAD TRAFFIC ACCIDENT 1463 0.0349
250 ADRENAL INSUFFICIENCY 423 0.0348
251 EPILEPSY 1055 0.0345
252 SMALL INTESTINAL RESECTION 40 0.0343
253 DRUG-INDUCED LIVER INJURY 1071 0.0341
254 CHOLANGITIS SCLEROSING 70 0.0340
255 VULVOVAGINAL CANDIDIASIS 46 0.0340
256 FREQUENT BOWEL MOVEMENTS 912 0.0337
257 BRONCHIECTASIS 224 0.0332
258 LIVER DISORDER 1461 0.0329
259 HAEMORRHAGIC STROKE 256 0.0327
260 LIMB DEFORMITY 51 0.0321
261 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 46 0.0320
262 LATENT TUBERCULOSIS 67 0.0320
263 ERYTHEMA NODOSUM 112 0.0319
264 INFLAMMATORY BOWEL DISEASE 310 0.0317
265 MYOSITIS 283 0.0315
266 RADICULOPATHY 83 0.0315
267 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2239 0.0314
268 SLEEP DISORDER 2213 0.0313
269 DISABILITY 604 0.0305
270 DELIRIUM 1060 0.0305
271 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 81 0.0304
272 INFLAMMATORY MARKER INCREASED 150 0.0302
273 GENERAL SYMPTOM 224 0.0299
274 ALOPECIA AREATA 52 0.0296
275 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1413 0.0294
276 SUDDEN HEARING LOSS 59 0.0291
277 SPINAL FUSION SURGERY 118 0.0291
278 SARCOIDOSIS 138 0.0290
279 ATYPICAL MYCOBACTERIAL INFECTION 41 0.0290
280 ANTINUCLEAR ANTIBODY POSITIVE 92 0.0283
281 GASTROINTESTINAL DISORDER 2501 0.0279
282 OSTEOPOROSIS 1147 0.0279
283 EXPOSURE DURING PREGNANCY 1730 0.0278
284 INTESTINAL STENOSIS 117 0.0277
285 HISTOPLASMOSIS 49 0.0277
286 INTERNATIONAL NORMALISED RATIO FLUCTUATION 57 0.0275
287 MACULAR OEDEMA 153 0.0273
288 MYELITIS TRANSVERSE 38 0.0270
289 IMMUNODEFICIENCY 402 0.0269
290 HEPATITIS 688 0.0269
291 ARTHRITIS 2110 0.0268
292 OCULAR HYPERTENSION 52 0.0268
293 EAR INFECTION 705 0.0265
294 MULTIPLE-DRUG RESISTANCE 82 0.0264
295 LYME DISEASE 88 0.0264
296 DRY MOUTH 2128 0.0262
297 ABDOMINAL DISCOMFORT 4385 0.0261
298 KERATOPATHY 41 0.0259
299 MONOCYTE COUNT INCREASED 93 0.0256
300 RHINITIS 206 0.0255
301 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 60 0.0253
302 FEAR OF INJECTION 180 0.0252
303 RHEUMATIC DISORDER 47 0.0243
304 CERVICAL DYSPLASIA 53 0.0243
305 ENTERITIS 154 0.0240
306 ARTHRITIS BACTERIAL 98 0.0239
307 EAR PAIN 461 0.0237
308 PAPILLOMA VIRAL INFECTION 39 0.0236
309 INFECTION 3340 0.0231
310 CYTOMEGALOVIRUS COLITIS 53 0.0230
311 ANTIPHOSPHOLIPID SYNDROME 37 0.0230
312 PLEURITIC PAIN 63 0.0228
313 TONGUE DISORDER 165 0.0228
314 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 53 0.0228
315 IMMUNOSUPPRESSION 201 0.0228
316 ABSCESS INTESTINAL 49 0.0227
317 DERMATOMYOSITIS 57 0.0225
318 ULCER 357 0.0224
319 ALOPECIA 4389 0.0223
320 DEFORMITY 208 0.0222
321 HYPOAESTHESIA 3321 0.0222
322 OCULAR DISCOMFORT 247 0.0220
323 PREGNANCY 431 0.0215
324 DYSPEPSIA 2117 0.0215
325 LYMPHOPROLIFERATIVE DISORDER 61 0.0207
326 IMPAIRED QUALITY OF LIFE 297 0.0206
327 SUBILEUS 43 0.0206
328 INFECTION SUSCEPTIBILITY INCREASED 45 0.0205
329 IRON DEFICIENCY 92 0.0204
330 PAROSMIA 154 0.0204
331 NECK PAIN 1139 0.0204
332 PHYSICAL DISABILITY 90 0.0203
333 GINGIVAL PAIN 162 0.0203
334 SINUSITIS 2072 0.0202
335 PERIPHERAL SWELLING 3099 0.0201
336 MIGRAINE 1919 0.0201
337 ADENOCARCINOMA 45 0.0201
338 NODULE 261 0.0200
339 HYPERSENSITIVITY 3699 0.0199
340 CREPITATIONS 59 0.0198
341 B-CELL LYMPHOMA 67 0.0197
342 BASAL CELL CARCINOMA 307 0.0197
343 APHTHOUS ULCER 152 0.0196
344 BACK DISORDER 318 0.0195
345 LARGE INTESTINAL ULCER 53 0.0195
346 SYNOVIAL CYST 88 0.0190
347 CONTUSION 1832 0.0190
348 GROWTH RETARDATION 56 0.0190
349 PUSTULE 45 0.0190
350 CARDIAC MURMUR 163 0.0188
351 GENERALISED OEDEMA 232 0.0187
352 HYPERSENSITIVITY VASCULITIS 49 0.0186
353 COLECTOMY 104 0.0184
354 THERAPY PARTIAL RESPONDER 287 0.0184
355 GLOMERULONEPHRITIS 45 0.0184
356 TUBULOINTERSTITIAL NEPHRITIS 338 0.0180
357 THROMBOCYTOSIS 66 0.0180
358 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
359 DERMATITIS EXFOLIATIVE GENERALISED 62 0.0178
360 HYPERTRANSAMINASAEMIA 124 0.0178
361 HYPERTENSION 3763 0.0177
362 RECTAL HAEMORRHAGE 757 0.0176
363 HYPERCALCAEMIA 215 0.0174
364 GASTROOESOPHAGEAL REFLUX DISEASE 1399 0.0174
365 PRODUCT USE ISSUE 3242 0.0172
366 URTICARIA 2886 0.0172
367 DIARRHOEA HAEMORRHAGIC 161 0.0172
368 PSORIASIS 2246 0.0172
369 SUBCUTANEOUS ABSCESS 82 0.0171
370 CONFUSIONAL STATE 2761 0.0171
371 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 85 0.0170
372 ANAL FISSURE 90 0.0168
373 MYCOBACTERIUM AVIUM COMPLEX INFECTION 45 0.0167
374 CONDITION AGGRAVATED 5087 0.0167
375 FOOT OPERATION 82 0.0166
376 CUTANEOUS VASCULITIS 60 0.0164
377 DRUG ERUPTION 291 0.0164
378 COLITIS 620 0.0163
379 FISTULA 183 0.0163
380 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 276 0.0162
381 TENDONITIS 247 0.0159
382 HAEMATOCHEZIA 876 0.0159
383 AMNESIA 1029 0.0158
384 RESPIRATORY DISORDER 473 0.0158
385 ABSCESS 252 0.0158
386 NASOPHARYNGITIS 2877 0.0156
387 ADVERSE EVENT 1437 0.0156
388 HEAD DISCOMFORT 271 0.0153
389 ADVERSE DRUG REACTION 1372 0.0153
390 ARTHRALGIA 6308 0.0152
391 MUSCULAR WEAKNESS 1695 0.0149
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 818 0.0149
393 GASTROINTESTINAL INFLAMMATION 116 0.0148
394 SKIN ULCER 379 0.0146
395 PHOTOPHOBIA 275 0.0146
396 MEMORY IMPAIRMENT 1970 0.0143
397 WEIGHT FLUCTUATION 150 0.0143
398 THERAPEUTIC RESPONSE DECREASED 868 0.0143
399 MEDICATION ERROR 795 0.0143
400 UPPER RESPIRATORY TRACT INFECTION 660 0.0143
401 WOUND COMPLICATION 49 0.0143
402 MENINGITIS ASEPTIC 64 0.0142
403 ABDOMINAL MASS 38 0.0142
404 LUNG ADENOCARCINOMA 42 0.0139
405 KLEBSIELLA INFECTION 70 0.0138
406 SKIN INFECTION 155 0.0138
407 IRITIS 42 0.0138
408 ENDOMETRIOSIS 65 0.0136
409 ABDOMINAL PAIN UPPER 2787 0.0135
410 QUALITY OF LIFE DECREASED 181 0.0135
411 WEIGHT INCREASED 2985 0.0133
412 COLITIS MICROSCOPIC 62 0.0131
413 PNEUMOCYSTIS JIROVECII PNEUMONIA 131 0.0130
414 OSTEOMYELITIS 236 0.0130
415 HEPATIC ENZYME ABNORMAL 65 0.0130
416 ASTHMA 1464 0.0129
417 SENSITIVITY TO WEATHER CHANGE 68 0.0129
418 LOSS OF EMPLOYMENT 39 0.0129
419 IMPAIRED WORK ABILITY 276 0.0129
420 DRUG LEVEL BELOW THERAPEUTIC 71 0.0129
421 KERATITIS 39 0.0128
422 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 49 0.0128
423 DRUG LEVEL DECREASED 129 0.0127
424 GUILLAIN-BARRE SYNDROME 61 0.0126
425 VAGINAL DISCHARGE 127 0.0125
426 ORGANISING PNEUMONIA 62 0.0125
427 TONSILLITIS 65 0.0124
428 BK VIRUS INFECTION 42 0.0124
429 PLATELET COUNT INCREASED 162 0.0124
430 PRODUCT USE IN UNAPPROVED INDICATION 3053 0.0123
431 BACTERIAL SEPSIS 40 0.0123
432 RASH 5346 0.0123
433 MUSCULOSKELETAL DISORDER 233 0.0122
434 ABDOMINAL ABSCESS 54 0.0122
435 SMALL INTESTINAL OBSTRUCTION 150 0.0122
436 MUCOUS STOOLS 60 0.0121
437 HEPATOTOXICITY 269 0.0121
438 ABSCESS LIMB 51 0.0120
439 INTESTINAL PERFORATION 133 0.0118
440 VASCULITIS 138 0.0118
441 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 346 0.0118
442 DECREASED APPETITE 2733 0.0118
443 MUSCLE SPASTICITY 143 0.0116
444 ENCEPHALITIS 80 0.0116
445 TONGUE ULCERATION 39 0.0115
446 SYMPTOM RECURRENCE 69 0.0115
447 CLOSTRIDIUM DIFFICILE INFECTION 250 0.0114
448 SPINAL PAIN 134 0.0114
449 ABDOMINAL PAIN 2658 0.0114
450 GASTROENTERITIS VIRAL 206 0.0114
451 HERPES SIMPLEX 74 0.0114
452 HYPOCALCAEMIA 215 0.0113
453 ALTERED STATE OF CONSCIOUSNESS 245 0.0113
454 IRON DEFICIENCY ANAEMIA 104 0.0113
455 ORAL DISCOMFORT 156 0.0112
456 HEPATIC STEATOSIS 209 0.0112
457 JOINT INJURY 237 0.0111
458 DIPLOPIA 288 0.0111
459 ORAL CANDIDIASIS 146 0.0111
460 OFF LABEL USE 9662 0.0110
461 IMMUNE THROMBOCYTOPENIA 50 0.0109
462 MALIGNANT MELANOMA 146 0.0109
463 EPSTEIN-BARR VIRUS INFECTION 68 0.0109
464 PRESYNCOPE 264 0.0108
465 DEPRESSION 2470 0.0108
466 WHITE BLOOD CELL COUNT INCREASED 415 0.0108
467 WOUND SECRETION 42 0.0107
468 PARAESTHESIA 1686 0.0107
469 CLOSTRIDIUM DIFFICILE COLITIS 113 0.0106
470 SEPTIC SHOCK 463 0.0106
471 PAIN IN EXTREMITY 3132 0.0106
472 INJECTION SITE REACTION 730 0.0106
473 PAIN 6472 0.0105
474 PYREXIA 3641 0.0105
475 PRE-ECLAMPSIA 50 0.0105
476 SPINAL STENOSIS 43 0.0104
477 SKIN REACTION 146 0.0104
478 ASCITES 302 0.0103
479 OPTIC NEURITIS 93 0.0102
480 EYE INFLAMMATION 97 0.0102
481 GASTROINTESTINAL INFECTION 91 0.0101
482 DEFAECATION URGENCY 71 0.0101
483 OEDEMA PERIPHERAL 1234 0.0101
484 PARAESTHESIA ORAL 145 0.0100
485 MENINGITIS 67 0.0100
486 HAEMATEMESIS 254 0.0100
487 HYPOALBUMINAEMIA 77 0.0099
488 STREPTOCOCCAL INFECTION 55 0.0099
489 FOOD INTOLERANCE 36 0.0098
490 CHEST PAIN 1807 0.0097
491 MUSCLE SPASMS 1785 0.0097
492 PNEUMONIA 3134 0.0097
493 CHOLANGITIS 60 0.0097
494 BOWEL MOVEMENT IRREGULARITY 74 0.0097
495 MALAISE 4214 0.0096
496 PEMPHIGOID 72 0.0095
497 MOUTH ULCERATION 201 0.0095
498 SKIN PAPILLOMA 38 0.0095
499 PULMONARY TOXICITY 67 0.0095
500 UNDERDOSE 690 0.0094
501 TINNITUS 434 0.0094
502 EXPOSURE VIA SKIN CONTACT 244 0.0094
503 HAEMATURIA 322 0.0094
504 PANCREATITIS 495 0.0094
505 ERYSIPELAS 47 0.0093
506 OESOPHAGEAL CANDIDIASIS 37 0.0093
507 POST PROCEDURAL INFECTION 75 0.0092
508 PSEUDOMONAS INFECTION 79 0.0092
509 RASH PRURITIC 499 0.0092
510 HERPES VIRUS INFECTION 53 0.0092
511 VISUAL IMPAIRMENT 1134 0.0091
512 VITAMIN B12 DEFICIENCY 37 0.0091
513 ANAL INCONTINENCE 82 0.0091
514 INSOMNIA 2426 0.0091
515 PRODUCT SUPPLY ISSUE 65 0.0091
516 SKIN LESION 248 0.0090
517 HYPERTENSIVE CRISIS 100 0.0090
518 INTENTIONAL DOSE OMISSION 254 0.0089
519 PROCTALGIA 57 0.0089
520 PAPILLOEDEMA 40 0.0088
521 DRUG INEFFECTIVE 11624 0.0088
522 FAECES SOFT 64 0.0088
523 TENDERNESS 90 0.0086
524 ATELECTASIS 83 0.0086
525 RENAL CELL CARCINOMA 42 0.0086
526 FURUNCLE 68 0.0086
527 BLINDNESS 346 0.0085
528 ARTHRITIS INFECTIVE 39 0.0084
529 LYMPHADENOPATHY 296 0.0084
530 ABDOMINAL DISTENSION 870 0.0083
531 FATIGUE 6470 0.0083
532 MATERNAL EXPOSURE BEFORE PREGNANCY 56 0.0082
533 VOMITING 3844 0.0082
534 GAIT DISTURBANCE 1559 0.0081
535 HYPOGAMMAGLOBULINAEMIA 53 0.0081
536 SKIN PLAQUE 68 0.0081
537 BONE DENSITY DECREASED 252 0.0080
538 METASTASES TO LYMPH NODES 54 0.0080
539 UROSEPSIS 73 0.0079
540 FOETAL DEATH 41 0.0079
541 TACHYCARDIA 701 0.0079
542 LABORATORY TEST ABNORMAL 232 0.0079
543 EYE PAIN 442 0.0078
544 RESPIRATORY TRACT INFECTION 204 0.0078
545 PULMONARY MASS 116 0.0078
546 SQUAMOUS CELL CARCINOMA OF SKIN 47 0.0078
547 AUTOIMMUNE HEPATITIS 54 0.0078
548 GASTROINTESTINAL TOXICITY 37 0.0077
549 LIMB DISCOMFORT 237 0.0077
550 LYMPHOPENIA 108 0.0076
551 ASPERGILLUS INFECTION 50 0.0076
552 DIARRHOEA 4907 0.0076
553 DRUG EFFECT LESS THAN EXPECTED 112 0.0076
554 POSTOPERATIVE WOUND INFECTION 51 0.0075
555 FLANK PAIN 70 0.0075
556 HEPATITIS B 45 0.0075
557 ENTEROCOCCAL INFECTION 36 0.0074
558 DECREASED IMMUNE RESPONSIVENESS 73 0.0074
559 ASTHENIA 2792 0.0074
560 SKIN DISORDER 247 0.0074
561 HEADACHE 4639 0.0074
562 COVID-19 PNEUMONIA 87 0.0074
563 BRONCHITIS 538 0.0073
564 DIFFUSE LARGE B-CELL LYMPHOMA 56 0.0073
565 SQUAMOUS CELL CARCINOMA 68 0.0072
566 SWELLING OF EYELID 45 0.0072
567 PRURITUS 2742 0.0071
568 COVID-19 1250 0.0071
569 FEELING HOT 434 0.0071
570 DEVICE MECHANICAL ISSUE 97 0.0071
571 HERPES ZOSTER 405 0.0070
572 WEIGHT DECREASED 1961 0.0070
573 HYPOKALAEMIA 321 0.0069
574 ESCHERICHIA INFECTION 57 0.0069
575 FOETAL EXPOSURE DURING PREGNANCY 563 0.0069
576 DEVICE DEFECTIVE 120 0.0069
577 OSTEOPENIA 105 0.0069
578 TOOTH ABSCESS 70 0.0069
579 HAEMATOCRIT DECREASED 136 0.0069
580 ANORECTAL DISCOMFORT 36 0.0068
581 INCORRECT DOSE ADMINISTERED BY DEVICE 177 0.0067
582 INTERSTITIAL LUNG DISEASE 324 0.0067
583 DIZZINESS 3337 0.0067
584 SWOLLEN TONGUE 208 0.0067
585 NEOPLASM MALIGNANT 443 0.0066
586 DEVICE MALFUNCTION 466 0.0066
587 ANAPHYLACTIC REACTION 366 0.0066
588 FLUID RETENTION 335 0.0066
589 SPINAL DISORDER 62 0.0065
590 LOW BIRTH WEIGHT BABY 52 0.0065
591 ODYNOPHAGIA 39 0.0065
592 RED BLOOD CELL COUNT DECREASED 185 0.0065
593 CYTOMEGALOVIRUS INFECTION 107 0.0064
594 NEOPLASM 74 0.0064
595 SARS-COV-2 TEST POSITIVE 85 0.0064
596 IMMUNE SYSTEM DISORDER 84 0.0064
597 PRODUCT QUALITY ISSUE 864 0.0064
598 CONJUNCTIVITIS 118 0.0064
599 ECZEMA 332 0.0063
600 ASPARTATE AMINOTRANSFERASE INCREASED 336 0.0063
601 BRONCHOPULMONARY ASPERGILLOSIS 49 0.0063
602 SPLENOMEGALY 74 0.0063
603 NEUROLOGICAL SYMPTOM 36 0.0063
604 MYOCARDITIS 72 0.0063
605 SEPSIS 700 0.0063
606 HEPATIC CYTOLYSIS 80 0.0063
607 GASTROINTESTINAL PAIN 69 0.0063
608 STAPHYLOCOCCAL INFECTION 206 0.0062
609 ENTEROCOLITIS 36 0.0062
610 SECRETION DISCHARGE 78 0.0062
611 LIVER FUNCTION TEST ABNORMAL 179 0.0061
612 PAPULE 43 0.0061
613 DRUG RESISTANCE 156 0.0061
614 CATARACT 361 0.0061
615 CARDIO-RESPIRATORY ARREST 253 0.0060
616 CANDIDA INFECTION 102 0.0060
617 RETINAL HAEMORRHAGE 43 0.0060
618 DISEASE RECURRENCE 287 0.0060
619 REBOUND EFFECT 68 0.0060
620 ALANINE AMINOTRANSFERASE INCREASED 369 0.0060
621 SCOLIOSIS 37 0.0060
622 DERMATITIS ALLERGIC 75 0.0060
623 LARGE INTESTINE POLYP 41 0.0059
624 MULTIPLE FRACTURES 97 0.0059
625 MALNUTRITION 66 0.0059
626 NAUSEA 4651 0.0059
627 ABORTION INDUCED 55 0.0058
628 LYMPHOMA 90 0.0058
629 MASS 81 0.0058
630 INTESTINAL OBSTRUCTION 218 0.0058
631 PNEUMONIA BACTERIAL 53 0.0058
632 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 195 0.0058
633 ACCIDENTAL OVERDOSE 211 0.0058
634 CAESAREAN SECTION 67 0.0057
635 NEEDLE ISSUE 167 0.0057
636 ABNORMAL FAECES 47 0.0057
637 CELLULITIS 288 0.0057
638 LEUKOPENIA 283 0.0057
639 BLOOD DISORDER 45 0.0056
640 GLAUCOMA 108 0.0056
641 ASPIRATION 61 0.0056
642 ILEUS 69 0.0055
643 DYSPNOEA 3141 0.0055
644 COMA 263 0.0055
645 AORTIC ANEURYSM 42 0.0055
646 INCORRECT PRODUCT ADMINISTRATION DURATION 119 0.0055
647 PLEURAL EFFUSION 334 0.0055
648 TRANSAMINASES INCREASED 122 0.0055
649 ORAL HERPES 107 0.0055
650 SKIN CANCER 118 0.0055
651 CORONAVIRUS INFECTION 36 0.0054
652 PREMATURE DELIVERY 86 0.0054
653 CYST 67 0.0054
654 FACIAL PARALYSIS 46 0.0054
655 RASH PUSTULAR 39 0.0053
656 APPENDICITIS 50 0.0053
657 SENSORY LOSS 43 0.0053
658 BLOOD PRESSURE SYSTOLIC INCREASED 104 0.0053
659 PHARYNGITIS 66 0.0053
660 PROCEDURAL PAIN 147 0.0053
661 NEUTROPHIL COUNT INCREASED 54 0.0053
662 NEPHROPATHY TOXIC 59 0.0053
663 DUODENAL ULCER 37 0.0052
664 VITAMIN D DEFICIENCY 51 0.0052
665 FEMUR FRACTURE 160 0.0052
666 DEEP VEIN THROMBOSIS 334 0.0051
667 BREAST CANCER STAGE I 47 0.0051
668 GASTRIC DISORDER 174 0.0051
669 ANXIETY 1442 0.0051
670 BLOOD TEST ABNORMAL 71 0.0050
671 BODY TEMPERATURE INCREASED 102 0.0050
672 KNEE OPERATION 49 0.0050
673 PRODUCT AVAILABILITY ISSUE 113 0.0050
674 GASTROENTERITIS 72 0.0049
675 POLYNEUROPATHY 59 0.0049
676 CARDIOVASCULAR DISORDER 125 0.0049
677 HAEMORRHOIDS 96 0.0049
678 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 881 0.0049
679 CARPAL TUNNEL SYNDROME 68 0.0049
680 BACTERIAL INFECTION 90 0.0048
681 HOSPITALISATION 739 0.0048
682 BRAIN NEOPLASM 44 0.0048
683 RETINAL DETACHMENT 44 0.0048
684 TOOTH INFECTION 62 0.0047
685 SPINAL OSTEOARTHRITIS 41 0.0047
686 ABORTION SPONTANEOUS 187 0.0047
687 BLOOD ALBUMIN DECREASED 37 0.0047
688 NIGHTMARE 161 0.0046
689 INCONTINENCE 49 0.0046
690 LOCALISED INFECTION 112 0.0046
691 PYELONEPHRITIS 40 0.0046
692 ILLNESS 475 0.0046
693 HEMIPARESIS 78 0.0046
694 VIRAL INFECTION 152 0.0046
695 COLON CANCER 68 0.0046
696 BACTERAEMIA 54 0.0045
697 LUNG INFILTRATION 40 0.0045
698 TREATMENT NONCOMPLIANCE 247 0.0045
699 VERTIGO 275 0.0045
700 EOSINOPHILIA 79 0.0045
701 RENAL TUBULAR NECROSIS 44 0.0045
702 INTERVERTEBRAL DISC PROTRUSION 98 0.0045
703 MUCOSAL INFLAMMATION 117 0.0045
704 UNEVALUABLE EVENT 336 0.0044
705 NERVE INJURY 49 0.0044
706 DEAFNESS 115 0.0044
707 CYTOPENIA 53 0.0043
708 DEVICE DELIVERY SYSTEM ISSUE 118 0.0043
709 DRUG DOSE OMISSION BY DEVICE 337 0.0043
710 BLOOD IRON DECREASED 51 0.0043
711 GASTROINTESTINAL CARCINOMA 39 0.0043
712 PRODUCT SUBSTITUTION ISSUE 245 0.0043
713 DERMATITIS 89 0.0042
714 CHILLS 494 0.0042
715 GROIN PAIN 37 0.0042
716 LEUKOCYTOSIS 76 0.0042
717 FALL 1392 0.0042
718 SURGERY 245 0.0042
719 RESPIRATORY SYNCYTIAL VIRUS INFECTION 36 0.0041
720 KIDNEY INFECTION 81 0.0041
721 PHOTOSENSITIVITY REACTION 68 0.0041
722 DIVERTICULITIS 114 0.0041
723 DEVICE RELATED INFECTION 63 0.0041
724 PHARYNGEAL SWELLING 40 0.0041
725 ERYTHEMA 839 0.0041
726 SYNCOPE 403 0.0040
727 PANCYTOPENIA 224 0.0040
728 THERAPY CHANGE 39 0.0040
729 OSTEONECROSIS OF JAW 97 0.0039
730 GASTRITIS 103 0.0039
731 POST PROCEDURAL COMPLICATION 75 0.0039
732 INJECTION SITE DISCOMFORT 41 0.0039
733 BONE DISORDER 71 0.0039
734 ABDOMINAL PAIN LOWER 98 0.0039
735 TOXIC SKIN ERUPTION 39 0.0039
736 THERAPY INTERRUPTED 276 0.0039
737 HIATUS HERNIA 50 0.0039
738 SCAB 44 0.0039
739 NEPHROLITHIASIS 176 0.0038
740 CYSTITIS 122 0.0038
741 MOVEMENT DISORDER 123 0.0038
742 THERAPEUTIC RESPONSE SHORTENED 127 0.0038
743 URINARY TRACT INFECTION 650 0.0038
744 LOSS OF CONSCIOUSNESS 483 0.0038
745 PULMONARY EMBOLISM 357 0.0038
746 BLINDNESS UNILATERAL 52 0.0037
747 MYALGIA 616 0.0036
748 ISCHAEMIC STROKE 64 0.0036
749 BACK PAIN 820 0.0035
750 GASTRIC ULCER 67 0.0035
751 CARDIAC FAILURE 278 0.0035
752 EYE INFECTION 39 0.0035
753 BRAIN FOG 54 0.0034
754 HYPOKINESIA 50 0.0034
755 SPINAL FRACTURE 69 0.0034
756 PREMATURE BABY 103 0.0034
757 PNEUMONITIS 93 0.0034
758 DRY EYE 169 0.0034
759 ATAXIA 40 0.0034
760 INTRAOCULAR PRESSURE INCREASED 43 0.0034
761 PRODUCT DOSE OMISSION ISSUE 980 0.0033
762 PERITONITIS 69 0.0033
763 PALPITATIONS 389 0.0033
764 COUGH 931 0.0033
765 ERECTILE DYSFUNCTION 85 0.0033
766 DIABETES MELLITUS 252 0.0033
767 PRODUCT PRESCRIBING ISSUE 72 0.0033
768 OSTEONECROSIS 108 0.0033
769 THROMBOCYTOPENIA 366 0.0033
770 HAEMOGLOBIN DECREASED 336 0.0033
771 BLOOD CREATININE INCREASED 213 0.0033
772 DEVICE LEAKAGE 141 0.0032
773 CARDIOMYOPATHY 48 0.0032
774 MENTAL DISORDER 141 0.0032
775 ACCIDENTAL EXPOSURE TO PRODUCT 333 0.0032
776 MYELODYSPLASTIC SYNDROME 46 0.0032
777 SWELLING FACE 206 0.0032
778 MULTIPLE SCLEROSIS 151 0.0032
779 RASH MACULO-PAPULAR 70 0.0031
780 DEVICE USE ISSUE 55 0.0031
781 FACE OEDEMA 53 0.0031
782 INFLUENZA 348 0.0031
783 RENAL IMPAIRMENT 262 0.0031
784 OROPHARYNGEAL PAIN 285 0.0031
785 NERVOUS SYSTEM DISORDER 96 0.0031
786 CHOLESTASIS 59 0.0031
787 ACUTE RESPIRATORY DISTRESS SYNDROME 54 0.0031
788 INJECTION SITE HAEMORRHAGE 243 0.0030
789 PERICARDIAL EFFUSION 70 0.0030
790 DEPRESSED MOOD 160 0.0030
791 BLOOD PRESSURE INCREASED 462 0.0030
792 SKIN HAEMORRHAGE 44 0.0030
793 ACUTE MYELOID LEUKAEMIA 46 0.0029
794 ANAEMIA 560 0.0029
795 SENSORY DISTURBANCE 47 0.0029
796 RESPIRATORY FAILURE 213 0.0029
797 RESPIRATORY TRACT CONGESTION 46 0.0029
798 PROTEINURIA 55 0.0029
799 BEDRIDDEN 38 0.0029
800 OCULAR HYPERAEMIA 137 0.0029
801 MUSCULOSKELETAL DISCOMFORT 49 0.0028
802 MULTIPLE ORGAN DYSFUNCTION SYNDROME 80 0.0028
803 DYSSTASIA 82 0.0028
804 PANCREATITIS ACUTE 63 0.0028
805 HERNIA 54 0.0028
806 FEELING JITTERY 53 0.0028
807 EATING DISORDER 59 0.0028
808 ANOSMIA 40 0.0028
809 INFLUENZA LIKE ILLNESS 227 0.0028
810 BREAST CANCER 257 0.0028
811 ACUTE MYOCARDIAL INFARCTION 81 0.0027
812 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
813 VISION BLURRED 368 0.0027
814 ORAL PAIN 60 0.0027
815 ANGIOEDEMA 118 0.0027
816 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 124 0.0027
817 LUNG NEOPLASM MALIGNANT 109 0.0026
818 FRACTURE 50 0.0026
819 PRODUCTIVE COUGH 126 0.0026
820 RASH ERYTHEMATOUS 126 0.0026
821 CENTRAL NERVOUS SYSTEM LESION 36 0.0026
822 LIMB INJURY 71 0.0026
823 SOMNOLENCE 525 0.0026
824 INTENTIONAL PRODUCT MISUSE 228 0.0026
825 LYMPHOCYTE COUNT DECREASED 46 0.0026
826 RENAL DISORDER 121 0.0026
827 NEURALGIA 63 0.0026
828 FUNGAL INFECTION 85 0.0025
829 INJECTION SITE PAIN 781 0.0025
830 DYSGEUSIA 189 0.0025
831 PAIN IN JAW 71 0.0025
832 CEREBRAL HAEMORRHAGE 89 0.0025
833 DYSPHONIA 145 0.0025
834 GAMMA-GLUTAMYLTRANSFERASE INCREASED 54 0.0024
835 RIB FRACTURE 50 0.0024
836 DEVICE ISSUE 217 0.0024
837 PRODUCT USE COMPLAINT 38 0.0024
838 THERAPY CESSATION 123 0.0024
839 DYSURIA 87 0.0024
840 INJECTION SITE RASH 72 0.0023
841 EYE DISORDER 77 0.0023
842 ACUTE RESPIRATORY FAILURE 45 0.0023
843 EYE SWELLING 87 0.0023
844 HAEMORRHAGE 244 0.0023
845 RHINORRHOEA 150 0.0023
846 DISEASE PROGRESSION 274 0.0023
847 POOR QUALITY SLEEP 49 0.0023
848 ACUTE KIDNEY INJURY 348 0.0023
849 FOOT FRACTURE 42 0.0022
850 DYSPNOEA EXERTIONAL 83 0.0022
851 ANGINA PECTORIS 63 0.0022
852 RASH PAPULAR 49 0.0022
853 METASTASES TO LIVER 38 0.0022
854 PNEUMONIA ASPIRATION 54 0.0022
855 SCAR 37 0.0022
856 NASAL CONGESTION 126 0.0021
857 NEUROPATHY PERIPHERAL 201 0.0021
858 THROMBOSIS 169 0.0021
859 DEMENTIA 58 0.0021
860 TOOTHACHE 37 0.0020
861 FEEDING DISORDER 41 0.0020
862 CHOLELITHIASIS 66 0.0020
863 HYPOGLYCAEMIA 97 0.0020
864 CONSTIPATION 436 0.0020
865 SKIN FISSURES 39 0.0020
866 OVERDOSE 426 0.0020
867 ACNE 148 0.0020
868 CEREBROVASCULAR ACCIDENT 327 0.0019
869 PRODUCT DISPENSING ERROR 42 0.0019
870 CEREBRAL INFARCTION 47 0.0019
871 INJECTION SITE PRURITUS 127 0.0019
872 SLEEP APNOEA SYNDROME 36 0.0019
873 INJECTION SITE BRUISING 149 0.0019
874 RASH MACULAR 65 0.0019
875 BLOOD ALKALINE PHOSPHATASE INCREASED 46 0.0019
876 HYPOTHYROIDISM 58 0.0018
877 FAECES DISCOLOURED 39 0.0018
878 RESPIRATORY DISTRESS 49 0.0018
879 HYPOTENSION 356 0.0018
880 HEPATIC FUNCTION ABNORMAL 66 0.0018
881 FLATULENCE 100 0.0018
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 92 0.0018
883 BLOOD POTASSIUM DECREASED 53 0.0018
884 LACRIMATION INCREASED 53 0.0018
885 DEVICE DIFFICULT TO USE 116 0.0018
886 SKIN EXFOLIATION 147 0.0017
887 BURNING SENSATION 122 0.0017
888 DRUG EFFECT INCOMPLETE 63 0.0017
889 HAEMOPTYSIS 48 0.0017
890 ANAPHYLACTIC SHOCK 44 0.0017
891 FEELING ABNORMAL 406 0.0017
892 BREAST CANCER FEMALE 45 0.0017
893 INJECTION SITE SWELLING 129 0.0017
894 BLOOD CREATINE PHOSPHOKINASE INCREASED 48 0.0017
895 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
896 HAEMATOMA 43 0.0017
897 APHASIA 50 0.0017
898 DRUG INTERACTION 262 0.0016
899 AGEUSIA 41 0.0016
900 DERMATITIS ATOPIC 86 0.0016
901 INJECTION SITE ERYTHEMA 199 0.0016
902 CRYING 57 0.0016
903 HYPOPHAGIA 40 0.0016
904 PANCREATIC CARCINOMA 45 0.0016
905 PROSTATE CANCER 124 0.0015
906 RENAL FAILURE 201 0.0015
907 PRODUCT PRESCRIBING ERROR 36 0.0015
908 COLORECTAL CANCER 72 0.0015
909 WHITE BLOOD CELL COUNT DECREASED 162 0.0015
910 EYE IRRITATION 86 0.0015
911 DEATH 1283 0.0015
912 ATRIAL FIBRILLATION 144 0.0015
913 ARRHYTHMIA 70 0.0015
914 LETHARGY 85 0.0015
915 HIP FRACTURE 47 0.0015
916 NEUTROPENIA 198 0.0015
917 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
918 HYPERHIDROSIS 184 0.0014
919 THERAPEUTIC RESPONSE UNEXPECTED 64 0.0014
920 BALANCE DISORDER 123 0.0014
921 POLLAKIURIA 59 0.0014
922 DRUG EFFECT DECREASED 76 0.0014
923 BLOOD BILIRUBIN INCREASED 38 0.0014
924 THROAT IRRITATION 63 0.0014
925 HYPONATRAEMIA 79 0.0014
926 COGNITIVE DISORDER 65 0.0014
927 TREMOR 230 0.0014
928 CHRONIC KIDNEY DISEASE 104 0.0014
929 PALLOR 37 0.0014
930 SEIZURE 157 0.0014
931 PSYCHOTIC DISORDER 40 0.0014
932 LIP SWELLING 45 0.0013
933 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
934 MOOD SWINGS 42 0.0013
935 PULMONARY OEDEMA 59 0.0013
936 PANIC ATTACK 48 0.0013
937 FEELING COLD 36 0.0013
938 SUICIDAL IDEATION 118 0.0013
939 CARDIAC FAILURE CONGESTIVE 103 0.0013
940 DYSPHAGIA 120 0.0013
941 CARDIAC DISORDER 117 0.0012
942 CHEST DISCOMFORT 127 0.0012
943 FEBRILE NEUTROPENIA 81 0.0012
944 HYPOACUSIS 52 0.0012
945 URINARY RETENTION 40 0.0012
946 INCORRECT DOSE ADMINISTERED 273 0.0012
947 TOXICITY TO VARIOUS AGENTS 199 0.0012
948 RENAL CANCER 55 0.0012
949 HYPERGLYCAEMIA 42 0.0012
950 DEVICE USE ERROR 40 0.0011
951 HEART RATE INCREASED 113 0.0011
952 SKIN DISCOLOURATION 52 0.0011
953 SPEECH DISORDER 59 0.0011
954 METABOLIC ACIDOSIS 36 0.0011
955 IRRITABILITY 67 0.0011
956 INJECTION SITE MASS 41 0.0011
957 DYSARTHRIA 40 0.0011
958 MYOCARDIAL INFARCTION 184 0.0011
959 DRY SKIN 140 0.0010
960 SKIN BURNING SENSATION 72 0.0010
961 NO ADVERSE EVENT 182 0.0010
962 EPISTAXIS 74 0.0010
963 NERVOUSNESS 51 0.0010
964 DEHYDRATION 130 0.0010
965 BONE PAIN 57 0.0010
966 PRODUCT STORAGE ERROR 84 0.0010
967 SUICIDE ATTEMPT 58 0.0010
968 VAGINAL HAEMORRHAGE 41 0.0009
969 RHABDOMYOLYSIS 39 0.0009
970 BLADDER CANCER 53 0.0009
971 HOT FLUSH 67 0.0009
972 FLUSHING 90 0.0009
973 SKIN IRRITATION 37 0.0008
974 BLOOD PRESSURE DECREASED 53 0.0008
975 CARDIAC ARREST 63 0.0008
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 135 0.0007
977 AGITATION 47 0.0006
978 HALLUCINATION 40 0.0005
979 COMPLETED SUICIDE 42 0.0005
980 DRUG DEPENDENCE 78 0.0005
981 BLOOD GLUCOSE INCREASED 82 0.0004
982 PLATELET COUNT DECREASED 39 0.0004
983 EMOTIONAL DISTRESS 41 0.0003